Inlec SA
3.0 FTEInlec reported total assets of €7.75m at the end of the 2025 financial year (annual accounts filed with the NBB on 29 Jul 2026), with 3 full-time equivalents.
The score of Inlec shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -29 % Total assets -24 % Headcount (avg FTE) +20 %
Accounts of the company itself (not consolidated).
The full file covers 15 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Inlec's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Jul 2026
- Year ended 31 Dec 2024filed on 30 Sep 2025
- Year ended 31 Dec 2023filed on 20 Sep 2024
- Year ended 31 Dec 2022filed on 17 Apr 2023
- Year ended 31 Dec 2021filed on 15 Jun 2022
Inlec's financial analysis
- Solvency71.4%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Inlec
Inlec's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0421.767.678
- VAT number
- BE0421767678
- Peppol
- Registered · 0208:0421767678 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 06 Aug 1981
- Registered office
- 1000 Brussels
- Size
- Micro · 3.0 FTE
- Latest accounts
- 2025 · filed on 29 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Inlec (SA) has been based in Brussels since 1981, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 11,916 € and equity of €5.53m; its revenue is not published. With 3.0 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 71.4%, above the median of its sector (37.8%).
Companies similar to Inlec
Companies in the same business, of comparable size and area, outside its group.
- Les Pharmacies de Gare Retail sale of pharmaceutical products Brussels · balance sheet €2.73m
- Pharmacie DE Neef - Duez Retail sale of pharmaceutical products Mons · balance sheet 181,026 €
- Prosana Retail sale of pharmaceutical products Oud-Turnhout · balance sheet €6.99m
- FVS Management Retail sale of pharmaceutical products Ouffet · balance sheet €5.40m
- HC Pharma Retail sale of pharmaceutical products Hamme (Vl.) · balance sheet €4.92m
- Pharmaclic Assets Retail sale of pharmaceutical products Evere · balance sheet €14.0m
- Pharmaceutica Retail sale of pharmaceutical products Lier · balance sheet €3.84m
- Apotheek Devriese Retail sale of pharmaceutical products Torhout · balance sheet €3.84m
Frequently asked questions about Inlec
What is the revenue of Inlec?
Inlec files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Inlec?
In Belgium, the VAT number is the company number prefixed with BE: BE0421767678 for Inlec, if the company is VAT-registered. Its company number (CBE) is 0421.767.678.
Where is the registered office of Inlec?
According to the CBE register, the registered office of Inlec is in 1000 Brussels.
What is the equity of Inlec?
At the close of the 2025 financial year, the equity of Inlec amounts to 5,533,319 €, a solvency of 71.4% of total assets.
How many people work at Inlec?
3.0 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Inlec?
The register lists 3 active mandates at Inlec. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Inlec
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →